Insiders / Gowen Maxine
Gowen Maxine
CIK 1280044personinsider
Companies
2
First seen
May 21, 2026
Last activity
Jun 8, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Aclaris Therapeutics, Inc. · ACRS | 33,334 | — |
| Passage BIO, Inc. · PASG | — | — |
All securities held
3 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Aclaris Therapeutics, Inc. | Common Stock | 33,334 |
| Aclaris Therapeutics, Inc. | Stock Option (Right to Buy)Derivative | 42,350 |
| Passage BIO, Inc. | Director Stock Option (right to buy)Derivative | 10,539 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -12K -100.00% | 0 0.00% of shares | low |
| Jun 4, 2026 | Grant | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | +11K | 10,987 <0.01% of shares | low |
| Jun 4, 2026 | Grant | ACRS Aclaris Therapeutics, Inc. Stock Option (Right to Buy) | — | +42K | 42,350 0.03% of shares | low |
| Jun 5, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +12K +53.23% | 33,334 0.02% of shares | low |
| May 19, 2026 | Grant | PASG Passage BIO, Inc. Director Stock Option (right to buy) | — | +11K | 10,539 0.33% of shares | low |